X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Ingersoll Rand with Indoco Remedies - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INGERSOLL RAND vs INDOCO REMEDIES - Comparison Results

INGERSOLL RAND    Change

Ingersoll Rand is a global diversified industrial company, engaged in the business of providing solutions for infrastructure development, industrial solutions, residential solutions and security technologies. Ingersoll-Rand manufactures a wide range ... More

INDOCO REMEDIES 
   Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    INGERSOLL RAND INDOCO REMEDIES INGERSOLL RAND/
INDOCO REMEDIES
 
P/E (TTM) x 19.5 44.3 44.0% View Chart
P/BV x 1.6 2.8 58.3% View Chart
Dividend Yield % 1.1 0.8 135.2%  

Financials

 INGERSOLL RAND   INDOCO REMEDIES
EQUITY SHARE DATA
    INGERSOLL RAND
Mar-17
INDOCO REMEDIES
Mar-17
INGERSOLL RAND/
INDOCO REMEDIES
5-Yr Chart
Click to enlarge
High Rs789360 218.9%   
Low Rs625249 250.8%   
Sales per share (Unadj.) Rs214.5119.0 180.2%  
Earnings per share (Unadj.) Rs24.58.4 292.7%  
Cash flow per share (Unadj.) Rs28.215.2 185.3%  
Dividends per share (Unadj.) Rs6.001.60 375.0%  
Dividend yield (eoy) %0.80.5 161.7%  
Book value per share (Unadj.) Rs336.370.7 475.6%  
Shares outstanding (eoy) m31.5792.15 34.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.32.6 128.7%   
Avg P/E ratio x28.936.4 79.3%  
P/CF ratio (eoy) x25.120.0 125.2%  
Price / Book Value ratio x2.14.3 48.8%  
Dividend payout %24.519.1 128.1%   
Avg Mkt Cap Rs m22,31528,083 79.5%   
No. of employees `0000.76.0 11.4%   
Total wages/salary Rs m9372,167 43.3%   
Avg. sales/employee Rs Th9,842.71,817.0 541.7%   
Avg. wages/employee Rs Th1,362.5359.0 379.6%   
Avg. net profit/employee Rs Th1,123.2127.7 879.7%   
INCOME DATA
Net Sales Rs m6,77210,968 61.7%  
Other income Rs m58840 1,480.4%   
Total revenues Rs m7,36011,007 66.9%   
Gross profit Rs m6821,565 43.6%  
Depreciation Rs m118633 18.6%   
Interest Rs m862 12.7%   
Profit before tax Rs m1,144909 125.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m371139 267.6%   
Profit after tax Rs m773771 100.3%  
Gross profit margin %10.114.3 70.6%  
Effective tax rate %32.415.3 212.7%   
Net profit margin %11.47.0 162.4%  
BALANCE SHEET DATA
Current assets Rs m9,1255,725 159.4%   
Current liabilities Rs m1,3465,454 24.7%   
Net working cap to sales %114.92.5 4,654.4%  
Current ratio x6.81.0 645.9%  
Inventory Days Days4762 75.7%  
Debtors Days Days5072 70.2%  
Net fixed assets Rs m1,2805,307 24.1%   
Share capital Rs m316184 171.3%   
"Free" reserves Rs m10,3006,331 162.7%   
Net worth Rs m10,6166,516 162.9%   
Long term debt Rs m01,323 0.0%   
Total assets Rs m12,05711,970 100.7%  
Interest coverage x145.815.6 932.0%   
Debt to equity ratio x00.2 0.0%  
Sales to assets ratio x0.60.9 61.3%   
Return on assets %6.57.0 93.1%  
Return on equity %7.311.8 61.5%  
Return on capital %10.912.4 87.5%  
Exports to sales %26.50-   
Imports to sales %20.10-   
Exports (fob) Rs m1,792NA-   
Imports (cif) Rs m1,363NA-   
Fx inflow Rs m1,7924,507 39.8%   
Fx outflow Rs m1,6031,141 140.5%   
Net fx Rs m1883,366 5.6%   
CASH FLOW
From Operations Rs m1,215886 137.0%  
From Investments Rs m1,407-1,706 -82.5%  
From Financial Activity Rs m-2311,316 -17.5%  
Net Cashflow Rs m2,391497 481.5%  

Share Holding

Indian Promoters % 0.0 59.2 -  
Foreign collaborators % 74.0 0.0 -  
Indian inst/Mut Fund % 7.2 12.5 57.6%  
FIIs % 0.5 6.0 8.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 18.3 22.4 81.7%  
Shareholders   19,522 12,805 152.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare INGERSOLL RAND With:   RELIGARE ENT.  COMPACT DISC  TATA INVEST. CORP.  CENTURY PLYBOARDS  GREENPLY IND  



Today's Market

Sensex Ends Day in Green; Metal Stocks Top Gainers(Closing)

After opening the day in green, share markets in India witnessed positive trading activity throughout the day and ended the day on a positive note.

Related Views on News

INDOCO REMEDIES Announces Quarterly Results (4QFY18); Net Profit Up 14.3%

Jun 19, 2018 | Updated on Jun 19, 2018

For the quarter ended March 2018, INDOCO REMEDIES has posted a net profit of Rs 205 m (up 14.3% YoY). Sales on the other hand came in at Rs 3 bn (down 2.6% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

H.G Infra Engineering Ltd. (IPO)

Feb 24, 2018

Should you subscribe to the IPO of H.G Infra Engineering Ltd.?

Amber Enterprises India Ltd. (IPO)

Jan 16, 2018

Should you subscribe to the IPO of Amber Enterprises India Ltd?

L&T: Transition Challenges Continue to Have an Effect (Quarterly Results Update - Detailed)

Nov 15, 2017

The readjustment to the continuing impact of demonetisation and the accelerated implementation of GST has upset the business environment and tripped growth in the economy.

BHEL: Margins Dip into the Negative (Quarterly Results Update - Detailed)

Aug 14, 2017

The company also saw order inflows of Rs 18 billion during the quarter, which was a massive 41% YoY lower than the previous year's quarter.

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

INGERSOLL RAND SHARE PRICE


Jun 20, 2018 (Close)

TRACK INGERSOLL RAND

  • Track your investment in INGERSOLL RAND with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INGERSOLL RAND

INGERSOLL RAND - JSW HOLDINGS COMPARISON

COMPARE INGERSOLL RAND WITH

MARKET STATS